NTCOC
INFI

Northern Trust Company of Connecticut’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Northern Trust Company of Connecticut’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$40K Hold
2,866
– – ﹤0.01% 1956
2013
Q3 		$50K Hold
2,866
– – ﹤0.01% 1912
2013
Q2 		$46K Buy
+2,866
New +$88.7K ﹤0.01% 1888

Other funds holding INFI

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Northern Trust Company of Connecticut's INFI Position: Q4 2013 in Review

Northern Trust Company of Connecticut held its Infinity Pharmaceuticals, Inc. (INFI) position steady in Q4 2013 at 2,866 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #1956.

Northern Trust Company of Connecticut first reported a position in INFI in Q2 2013 and has held it in 3 quarters since. The position peaked at $50K in Q3 2013. 104 funds tracked by Wall St. Rank hold INFI as of Q4 2013.

  • Northern Trust Company of Connecticut held 2,866 shares of Infinity Pharmaceuticals, Inc. worth $40K as of Q4 2013.
  • Northern Trust Company of Connecticut left its Infinity Pharmaceuticals, Inc. share count unchanged in Q4 2013.
  • Infinity Pharmaceuticals, Inc. made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1956 holding.
  • Northern Trust Company of Connecticut first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and has held it in 3 quarters since.
  • Northern Trust Company of Connecticut's Infinity Pharmaceuticals, Inc. position peaked at $50K in Q3 2013.
  • 104 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.